Home / Guides / Is compounded tirzepatide legal?
Clear rules. Calm answers.
Is compounded tirzepatide legal, safe and still available in 2026?
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
Yes, compounded tirzepatide is legal when a state-licensed 503A pharmacy prepares it for your prescription and your prescriber documents a significant difference for you. It isn’t FDA-approved. Routine copies stopped after the shortage ended on December 19, 2024. On August 27, 2026, the Fifth Circuit upheld the FDA’s decision that the shortage is over.
- Legal: for an individual prescription (503A)
- Not: FDA-approved, or a generic
- Courts: upheld the FDA in August 2026
Compounded tirzepatide legal status in 2026: the short answer
- Legal?
- Yes, for an individual prescription from a state-licensed 503A pharmacy
- FDA-approved?
- No, and it isn’t a generic
- 503B facilities
- Can’t make it from bulk tirzepatide
- The courts
- The Fifth Circuit upheld the FDA on August 27, 2026
- At NexLife
- Licensed providers, named state-licensed pharmacies
Questions about the rules or your medication? Call or text
4.8 out of 5 on Trustpilot · LegitScript certified
About 3 minutes of health questions. No insurance needed.
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
At a glance
When is compounded tirzepatide legal? The rules at a glance
| Question | Answer |
|---|---|
| When is it legal? | When a state-licensed 503A pharmacy prepares it for your prescription and your prescriber documents a significant difference for you |
| Is it FDA-approved? | No. Brand-name Zepbound is |
| Can pharmacies make routine copies? | No. Routine copies stopped after the shortage ended on December 19, 2024 |
| What did the courts say? | On August 27, 2026, the Fifth Circuit upheld the FDA’s decision that the shortage is over |
| Can 503B facilities make it? | Not from bulk tirzepatide |
| Is buying it online legal? | Yes, with a licensed provider’s prescription, filled by a state-licensed 503A pharmacy |
From the FDA’s own pages and the Fifth Circuit’s ruling.
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Yes, it’s legal when a state-licensed 503A pharmacy prepares it for your prescription and your prescriber documents a significant difference.
- Not FDA-approved: the FDA hasn’t reviewed compounded tirzepatide for safety, effectiveness or quality.
- Routine copies ended with the shortage, which the FDA confirmed was resolved on December 19, 2024.
- The courts agreed: on August 27, 2026, the Fifth Circuit upheld the FDA’s decision that the shortage is over.
- 503B facilities can’t make it from bulk tirzepatide. At our October 30, 2026 check, the FDA’s proposal to exclude it wasn’t final.
- At NexLife, licensed providers prescribe it and named state-licensed 503A pharmacies fill it: $139 a month on the 12-month plan.
The rules
What are the rules for compounded tirzepatide in 2026?
Compounded for you, by prescription. A state-licensed 503A pharmacy prepares it for an individual patient’s prescription.
Not a routine copy. A pharmacy can’t regularly copy an approved drug unless the prescriber documents a change that makes a significant difference for that patient.
“…unless a prescriber determines and documents the compounded drug product contains a change that produces a significant difference from the commercially available drug product for an identified individual patient.”
U.S. Food and Drug Administration, FDA clarifies policies for compounders as nationalGLP-1 supply begins to stabilize
A narrow allowance. The FDA says it won’t act against a pharmacy that fills four or fewer copies in a calendar month. That’s an enforcement policy, not a change in the law.
An added vitamin isn’t a loophole. In the FDA’s example, a
Honest claims only. Companies can’t call compounded products generic, the same as Zepbound or Wegovy, or proven. The FDA treats claims like these as false or misleading.
Two pathways
How do 503A pharmacies differ from 503B outsourcing facilities?
| 503A pharmacy | 503B outsourcing facility | |
|---|---|---|
| What it is | A state-licensed pharmacy compounding for individual patients | A facility registered with the FDA as an outsourcing facility |
| Prescriptions | Compounds for an individual patient’s prescription | Can compound with or without one |
| Main oversight | State boards of pharmacy; the FDA can also inspect | The FDA, on a risk-based schedule |
| Federal manufacturing rules | Not subject to them | Subject to them |
| Tirzepatide in 2026 | For an individual prescription, when the prescriber documents a significant difference for that patient | Can’t compound it from bulk tirzepatide: it isn’t on the 503B bulks list or the shortage list |
| FDA-approved? | No | No |
Neither pathway makes a compounded drug FDA-approved. NexLife’s prescriptions are filled by state-licensed 503A pharmacies.
“This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers
Step by step
How do you get compounded tirzepatide legally, step by step?
Five checks that follow the rules on this page, from what it is to the label on your vial.
- Know it isn’t FDA-approved. The FDA hasn’t reviewed compounded tirzepatide for safety, effectiveness or quality. Brand-name Zepbound, made by Eli Lilly, is FDA-approved.
- Start with a licensed provider. A licensed provider has to prescribe it for you, after a review of your history. A product sold without a prescription isn’t 503A compounding.
- Expect a documented reason. It’s available only if your prescriber determines it offers a significant difference for you compared with an FDA-approved product, documented on the prescription.
- Confirm a state-licensed 503A pharmacy. A state-licensed 503A pharmacy prepares it for your prescription alone. In 2026, 503B outsourcing facilities can’t make it from bulk tirzepatide.
- Check the label. The FDA has reported fraudulent compounded products with false labels, so check that a licensed pharmacy is named on yours.
From the prescription to the label: five checks before you start compounded tirzepatide.
Did the rules for compounded GLP-1s change?
The rules around compounded
- Rules changed. Both shortages were declared resolved, and the FDA restated what compounders may do.
- Headlines got loud. Some sounded like everything was ending. It isn’t that simple.
- Answers got vague. Too many pages skip the sources. Every rule here links to the FDA.
How does NexLife prescribe compounded tirzepatide within the rules?
- A licensed provider decides. A licensed provider reviews your history before anything is prescribed.
- One flat price. $139 for tirzepatide and $119 for semaglutide on 12 months, or $169 and $139 month to month, at every dose.
- Named pharmacies. State-licensed pharmacies, named on NexLife’s plan pages.
Real people, real answers. Call or text
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.
Timeline
What happened to compounded tirzepatide, and when?
From the FDA’s own updates and the court’s ruling.
After re-evaluating, the FDA confirms the tirzepatide shortage is resolved.
The FDA determines the semaglutide shortage is resolved.
The grace period ends for pharmacies making copies of tirzepatide: March 5 for 503A pharmacies, March 19 for 503B facilities.
The FDA announces steps against mass-marketed compounded
GLP-1s and misleading ads.The FDA restates the conditions compounders must meet. Neither drug is in shortage.
The FDA proposes excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list.
The FDA extends the comment period on that proposal to July 30, 2026, in a Federal Register notice.
The Fifth Circuit upholds the FDA’s decisions that the tirzepatide and semaglutide shortages are over.
At our latest check, we found no final FDA decision on the 503B proposal.
“The FDA did not act arbitrarily in concluding that Eli Lilly’s supply would meet or exceed projected demand.”
U.S. Court of Appeals for the Fifth Circuit, Outsourcing Facilities Association v. FDA, No. 25-10600 (August 27, 2026)
Safeguards
What does a licensed tirzepatide program look like?
The FDA has reported fraudulent compounded products with false labels. These are NexLife’s safeguards.
A licensed provider decides
NexLife prescriptions come only from licensed providers with affiliated, physician-owned medical groups, after a review of your history.
Named, licensed pharmacies
Prescriptions are filled by Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA), each state-licensed; which one fills your prescription depends on your location, your provider’s direction and pharmacy availability.
LegitScript certified
NexLife is LegitScript-certified. Every prescription goes to a state-licensed 503A partner pharmacy, and a licensed provider decides first whether treatment is right for you.
A real reason to compound
Compounded tirzepatide is available only if your prescriber determines that it provides a significant difference for you compared to an FDA-approved product.
Questions about your medication? Ask us.
Call or text
Vial math
How many units is your tirzepatide dose?
It depends on your vial’s strength. Here are the label’s doses at one example strength, with the math to check your own.
| Dose | mL at 25 mg/mL | Units (U-100) | On the label |
|---|---|---|---|
| 2.5 mg | 0.1 mL | 10 units | Starting dose, for 4 weeks |
| 5 mg | 0.2 mL | 20 units | A maintenance dose |
| 7.5 mg | 0.3 mL | 30 units | A step up |
| 10 mg | 0.4 mL | 40 units | A maintenance dose |
| 12.5 mg | 0.5 mL | 50 units | A step up |
| 15 mg | 0.6 mL | 60 units | The maximum, and a maintenance dose |
The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.
25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Is compounded tirzepatide legal? Your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Is compounded tirzepatide legal in 2026?
Yes, when a state-licensed 503A pharmacy prepares it for an individual prescription and the prescriber documents a significant difference for that patient. It isn’t FDA-approved. Routine copies stopped after the FDA confirmed the shortage was resolved on December 19, 2024, and on August 27, 2026, the Fifth Circuit upheld that decision.
Did the courts rule on compounded tirzepatide?
Yes. On August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit upheld the FDA’s decisions that the tirzepatide and semaglutide shortages are over. That limits routine copying, not individual prescriptions that meet the rules: a state-licensed 503A pharmacy can still prepare it when the prescriber documents a significant difference for you.
Is compounded tirzepatide being banned?
No ban has been announced. On April 30, 2026, the FDA proposed excluding tirzepatide from the 503B bulks list, which affects outsourcing facilities, not 503A prescriptions. At our latest check, on October 30, 2026, we found no final decision. A 503A pharmacy can still prepare it for your prescription when the rules are met.
Is compounded tirzepatide a generic version of Zepbound?
No. Compounded tirzepatide is a different product: it isn’t FDA-approved, and a state-licensed pharmacy prepares it for one patient’s prescription. Brand-name Zepbound, made by Eli Lilly, is FDA-approved. A provider prescribes compounded tirzepatide only when it offers a significant difference for you compared with an FDA-approved product.
Is compounded tirzepatide safe?
It can be, when a licensed prescriber orders it and a state-licensed pharmacy prepares it, with a label you can read. It isn’t FDA-approved, so the FDA hasn’t reviewed it for safety, effectiveness or quality. The FDA has reported fraudulent compounded products with false labels, so check that a licensed pharmacy is named.
What’s the difference between 503A and 503B?
503A pharmacies are state-licensed and compound for individual prescriptions, overseen mainly by state boards of pharmacy. 503B outsourcing facilities register with the FDA, can compound with or without a prescription, and follow federal manufacturing rules. In 2026, 503B facilities can’t make tirzepatide from bulk ingredients, and neither pathway makes a compounded drug FDA-approved.
Can 503B outsourcing facilities make tirzepatide?
Not from bulk tirzepatide. It isn’t on the 503B bulks list or the FDA’s shortage list, and on April 30, 2026, the FDA proposed excluding it from the list; at our latest check, on October 30, 2026, we found no final decision. A state-licensed 503A pharmacy can still prepare it for an individual prescription when the rules are met.
What does “significant difference” mean?
A change in the compounded product that the prescriber determines makes a clinical difference for that patient, documented on the prescription. The FDA leaves that determination to the prescriber. Without it, a pharmacy can’t regularly copy an approved drug; the FDA says it won’t act against a pharmacy that fills four or fewer copies in a calendar month.
Is it legal to buy compounded tirzepatide online?
Yes, with a prescription. A licensed provider has to prescribe it for you, and a state-licensed 503A pharmacy prepares it for you alone when the prescriber documents a significant difference for you. A product sold without a prescription isn’t 503A compounding. Here’s how to get a tirzepatide prescription online.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide isn’t FDA-approved, and the FDA hasn’t reviewed it for safety, effectiveness or quality. Brand-name Zepbound, made by Eli Lilly, is. A provider prescribes compounded tirzepatide only when it offers a significant difference for you. Neither a 503A pharmacy nor a 503B outsourcing facility makes a compounded drug FDA-approved.
Does adding B12 make compounded tirzepatide legal?
No. An added vitamin isn’t a loophole. In the FDA’s example, a GLP-1 with B12 can still count as essentially a copy when both amounts are within 10% of approved strengths. A pharmacy can’t regularly copy an approved drug unless the prescriber documents a significant difference for that patient.
Which pharmacies fill compounded tirzepatide prescriptions at NexLife?
Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA), both state-licensed 503A pharmacies. Which one fills yours depends on your location, your provider’s direction and pharmacy availability. NexLife doesn’t make or compound medication, and a licensed provider decides first whether treatment is right for you.
Is the FDA cracking down on compounded tirzepatide?
Yes. On February 6, 2026, the FDA said it intends to take action against non-FDA-approved GLP-1 drugs, with steps against mass-marketed compounded GLP-1s and misleading ads. Individual prescriptions that a state-licensed 503A pharmacy prepares, with a documented significant difference for the patient, are still allowed.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
“Drugs compounded in outsourcing facilities are subject to current good manufacturing practice (CGMP) requirements. By contrast, drugs compounded by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a physician, in accordance with the conditions of section 503A of the FD&C Act, are not.”
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Checked the FDA’s compounding rules and 2026 statements, the 503B bulks-list proposal and its comment period, the Fifth Circuit’s August 27, 2026 ruling, and NexLife’s physician and pharmacy disclosures.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
A licensed provider, a named pharmacy, one price.
Start online in about 3 minutes. A licensed provider decides if tirzepatide is right for you.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national
GLP-1 supply begins to stabilize. - U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.
- U.S. Food and Drug Administration. Guidance for entities considering whether to register as outsourcing facilities under section 503B.
- U.S. Food and Drug Administration. FDA intends to take action against non-FDA-approved
GLP-1 drugs (February 6, 2026). - U.S. Food and Drug Administration. FDA proposes to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026).
- Federal Register. List of bulk drug substances for which there is a clinical need under section 503B (May 1, 2026).
- Federal Register. List of bulk drug substances for which there is a clinical need under section 503B: extension of comment period (June 26, 2026). Read November 1, 2026.
- U.S. Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10600 (Aug. 27, 2026).
- U.S. Food and Drug Administration. FDA’s concerns with unapproved
GLP-1 drugs used for weight loss. - NexLife. Compounded tirzepatide plans.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- LegitScript. LegitScript certification record for NexLife.us.
- NexLife. Compounded semaglutide plans.
- Ro: weight loss program pricing. Checked November 1, 2026.
- Hims: Zepbound KwikPen. Checked November 1, 2026.
- Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
- Mochi Health: FAQs (membership and medication prices). Checked November 1, 2026.
- Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
- Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
- U.S. Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10758 (Aug. 27, 2026) (semaglutide). Checked November 1, 2026.